EU Report Announces Drugmaker Probes Over Deals
Citing concerns over settlements between generic- and brand-name drug companies that may slow the arrival of cheaper medicines on the market, the European Commission announced formal investigations of a French drugmaker...To view the full article, register now.
Already a subscriber? Click here to view full article